275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2021. Parexel International Corporation.
SCRIP AWARDS 2020 WINNER
Decentralized Clinical Trials (DCTs)
The future is now!
We deliver DCTs with patients at the heart of our approach. Our fully virtual and hybrid DCTs (inclusive of home nursing) demonstrate the Parexel Promise – our commitment to treating patients and caregivers as an essential part of our team of experts.
Risk-based Quality Management (RBQM) Services
The new world order of clinical research demands a fresh look at end-to-end clinical practices. Parexel’s approach to risk-based quality management (RBQM) is a holistic risk strategy rooted in Quality by Design principles, that relies on critical data to inform decision-making throughout clinical programs and trials.
Regulatory & Access Consulting
Connect with an expert from our 1000+ strong Regulatory & Access consulting team to see how our integrated expertise can strengthen your development strategy. Our consulting group includes ~100 former regulators/HTA assessors alongside industry luminaries - experts that apply first-hand knowledge of how regulators and payers think to help you foresee and address regulatory and market access hurdles. Our team never stops, relentlessly searching for solutions, because patients can’t wait.
Navigating COVID-19
During this time, we continue to be committed to our customers’ business while putting the safety of patients, partners and our employees at the heart of everything we do.
The future of real-world evidence with Dr. Scott Gottlieb
Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration, and industry leaders met recently for a roundtable discussion with Parexel and Pharmaceutical Executive to discuss the current and evolving role of real-world evidence for regulatory approvals and drug development.
Live Virtual Panel: Partnering with Patients to Transform Rare Disease Research
Despite their heterogeneity, rare diseases share commonalities that necessitate a highly orchestrated approach to developing new treatments and cures – one that integrates the voices of patients, providers, researchers and regulators to fully appreciate and overcome the challenges. Hear from patients, a rare parent and Parexel rare disease experts on how they’re pushing to achieve this goal. Now available On-demand.
Get reliable COVID-19 information in one place
The future of clinical trials is now, and we're committed to creating innovations that make this research accessible to more people. That's why, together with Innoplexus, we've made a single, virtual space for everyone to access reliable COVID-19 information for free.
Solutions Highlights
Regulatory & Access
Bringing together the industry’s best minds for smarter, faster and sustained patient access.
Decentralized Clinical Trials and Patient Needs
Decentralized Clinical Trials and Patient Needs
Parexel FSP: The Bigger Picture
The future of clinical trials is now and there’s #NoGoingBack
Parexel Biotech – designed with biotech’s unique way of working in mind
Innovation: Today’s patients, tomorrow’s medicines.
Patient registries: Defining the patient
Parexel's #KeepingPatientsFirst
Parexel Biotech: The value of patient-centric approaches - escaping the clinic
Patient Centricity Roundtable
Parexel With Heart
Get reliable COVID-19 information in one place
The future of clinical trials is now, and we're committed to creating innovations that make this research accessible to more people. That's why, together with Innoplexus, we've made a single, virtual space for everyone to access reliable COVID-19 information for free.
Participate in a clinical trial
Interested in learning more about how to volunteer in a clinical trial? Find information about participating in a clinical study here.
- Episode 15: Pandemic Preparedness: Investing in the future of infectious disease vaccine development
- Episode 14: Why Parents and Children Join Research Studies: CISCRP’s 2020 Pediatric Perceptions & Insights Survey Reveals Critical Insights
- Episode 13: The New Pragmatism: Clinical Trials, Investment and Regulations Post-COVID-19
- Episode 12: ASCO20 Debrief: The latest in cell and gene therapy
- Episode 11: Maintaining Clinical Trial Continuity During COVID-19: The Patient Perspective
- Episode 10: The emerging role of wearables in clinical trials
- Episode 9: Making the Most of Functional Service Provider (FSP) Relationships
- Episode 8: Performing clinical trials in a shifting development landscape
- Episode 7: International Women’s Day: Insights from Ascending Davos
- Episode 6: The opportunity for biotechs in precision medicine: driving value and bringing important new therapies to patients
Insights from Parexel
In the News
PRESS RELEASE
01.08.21Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
Upcoming Events
UPCOMING EVENT
March 1 - March 10,2021USP-APEC Center of Excellence for Advanced Therapies Pilot Virtual Training Workshop on “Starting and Raw Materials for Advanced Therapies”